60 DEGREES PHARMACEUTICALS, INC.: Orca Capital AG amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Orca Capital AG amended its Schedule 13G filing on 60 Degrees Pharmaceuticals, Inc., disclosing a change in its passive stake in the company. The filing, submitted to the SEC under accession number 0001493152-26-051423, updates the investor's previously reported position in the small-cap pharmaceutical developer. Schedule 13G amendments are typically filed when a holder's ownership crosses certain thresholds or when previously reported information materially changes. The exact size and direction of the stake adjustment were not detailed in the filing headline. Investors will watch for further disclosures to clarify whether Orca Capital increased or reduced its position in 60 Degrees Pharmaceuticals.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
60 Degrees Pharmaceuticals, Inc., Orca Capital AG